 Tandem Diabetes Inc. TNDM, -1.55 shares gained nearly 7 in after-hours trading Tuesday, following preliminary quarterly sales information that lived up to reduced guidance from the company. Tandem disclosed that it reached sales of 221 million in the fourth quarter, up from 210 million a year ago, for an annual total of 802 million. 